MDMB-FUBINACA (aka MDMB(N)-Bz-F), chemical name Methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, is a fluoridated indazole-3-carboxamide synthetic compound (Fig. 1) which is considered a designer drug or a new psychoactive substance (NPS). Regarding the pharmacological effect of this compound, it might be referred as a synthetic cannabinoid (SCB) or cannabimimetic drug. Even though MDMB-FUBINACA is available worldwide via the Internet and the abuse of the drug seems to be increasing [1] there is little to no scientific/medical data concerning the pharmacology, pharmacokinetics, biotransformation or toxicology of the drug.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2if1V4N
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Be a Responsible Dog Owner . Among companion animals, dogs are unmatched in their devotion, loyalty and friendship to humankind. Anyone who ...
-
Nothing is impossible, the word itself says 'I'm possible'! - Audrey Hepburn quotes from from #AlexandrosSfakianakis via Alexa...
-
Masters Thesis Proposal Outline INTRODUCTION (1 PAGE) • What is the general topic area • Why this topic is relevant/important (how important...
-
Abstract We present a case of small coronary sinus defect detected after transcatheter device closure of a large secundum atrial septal de...
-
Free world history papers, essays, and research papers. from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.t...
-
Publication date: Available online 5 April 2017 Source: European Annals of Otorhinolaryngology, Head and Neck Diseases Author(s): C.A. Ri...
-
Business Cover Letter Writing. The business professional can include a fairly broad group, so make sure you that cold cover letters have a j...
-
Publication date: February 2017 Source: Cryobiology, Volume 74 Author(s): Maria M. Jenderek, Justin D. Tanner, Barbara D. Ambruzs, Mark We...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου